BG60755B2 - Мометазонфуроат монохидрат, метод за получаването му и фармацевтичен състав - Google Patents

Мометазонфуроат монохидрат, метод за получаването му и фармацевтичен състав Download PDF

Info

Publication number
BG60755B2
BG60755B2 BG098564A BG9856494A BG60755B2 BG 60755 B2 BG60755 B2 BG 60755B2 BG 098564 A BG098564 A BG 098564A BG 9856494 A BG9856494 A BG 9856494A BG 60755 B2 BG60755 B2 BG 60755B2
Authority
BG
Bulgaria
Prior art keywords
monohydrate
mometasone furoate
water
furoate
pregnadiene
Prior art date
Application number
BG098564A
Other languages
Bulgarian (bg)
English (en)
Inventor
Pui-Ho Yuen
Charles Eckhart
Teresa Etlinger
Nancy Levine
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24320279&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG60755(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corporation filed Critical Schering Corporation
Publication of BG60755B2 publication Critical patent/BG60755B2/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG098564A 1990-09-10 1994-02-24 Мометазонфуроат монохидрат, метод за получаването му и фармацевтичен състав BG60755B2 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58023990A 1990-09-10 1990-09-10

Publications (1)

Publication Number Publication Date
BG60755B2 true BG60755B2 (bg) 1996-02-29

Family

ID=24320279

Family Applications (1)

Application Number Title Priority Date Filing Date
BG098564A BG60755B2 (bg) 1990-09-10 1994-02-24 Мометазонфуроат монохидрат, метод за получаването му и фармацевтичен състав

Country Status (35)

Country Link
US (1) US6180781B1 (cs)
EP (1) EP0548114B1 (cs)
JP (1) JPH0725789B2 (cs)
KR (1) KR960013445B1 (cs)
CN (1) CN1030920C (cs)
AT (1) ATE113604T1 (cs)
AU (1) AU663471B2 (cs)
BG (1) BG60755B2 (cs)
CA (1) CA2091360C (cs)
CZ (1) CZ281318B6 (cs)
DE (2) DE69104991T2 (cs)
DK (1) DK0548114T5 (cs)
EE (1) EE02962B1 (cs)
ES (1) ES2065701T3 (cs)
FI (1) FI111078B (cs)
HK (1) HK185996A (cs)
HR (1) HRP920383B1 (cs)
HU (1) HU213401B (cs)
IE (1) IE67056B1 (cs)
IL (1) IL99437A (cs)
LU (1) LU90366I2 (cs)
MX (2) MX9203396A (cs)
MY (1) MY106644A (cs)
NL (1) NL980012I2 (cs)
NO (1) NO300548B1 (cs)
NZ (1) NZ239711A (cs)
OA (1) OA09772A (cs)
PH (1) PH30443A (cs)
PL (1) PL165803B1 (cs)
PT (1) PT98905B (cs)
SI (1) SI9111497A (cs)
TW (2) TW229208B (cs)
WO (1) WO1992004365A1 (cs)
YU (1) YU48666B (cs)
ZA (1) ZA917148B (cs)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960013445B1 (ko) * 1990-09-10 1996-10-05 쉐링 코포레이션 모메타손 푸로에이트 모노하이드레이트 및 이의 제조방법
PE44995A1 (es) 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
US5837699A (en) 1994-01-27 1998-11-17 Schering Corporation Use of mometasone furoate for treating upper airway passage diseases
US5886200A (en) * 1996-07-01 1999-03-23 Schering Corporation Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
CN1059476C (zh) * 1996-08-21 2000-12-13 邓维鹏 金黄色铝合金硒盐电解着色方法
US6187765B1 (en) * 1997-10-09 2001-02-13 Schering Corporation Mometasone furoate suspensions for nebulization
WO1999018971A1 (en) * 1997-10-09 1999-04-22 Schering Corporation Mometasone furoate suspensions for nebulization
MY133181A (en) * 1998-09-10 2007-10-31 Schering Corp Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
NZ515134A (en) 1999-05-04 2004-01-30 Strakan Ltd Androgen glycosides and androgenic activity thereof
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
US7811606B2 (en) 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US9808471B2 (en) 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
RU2387646C2 (ru) * 2003-08-29 2010-04-27 Рэнбакси Лабораториз Лимитед Ингибиторы фосфодиэстеразы типа-iv
US20070259874A1 (en) * 2003-11-26 2007-11-08 Palle Venkata P Phosphodiesterase Inhibitors
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
EP1934219A1 (en) 2005-09-16 2008-06-25 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
RU2008119323A (ru) 2005-10-19 2009-11-27 Рэнбакси Лабораториз Лимитед (In) Фармацевтические композиции мускаринового рецептора
CA2626628A1 (en) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type iv inhibitors
CN100389121C (zh) * 2005-12-09 2008-05-21 天津药业集团有限公司 糠酸莫美他松中间体21-羟的制备方法
CN100436473C (zh) * 2005-12-09 2008-11-26 天津药业集团有限公司 糠酸莫美他松中间体21-酯及制法
DE102006034883A1 (de) * 2006-07-25 2008-01-31 Hermal Kurt Herrmann Gmbh & Co. Ohg Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat
EP2066661A2 (en) * 2006-09-22 2009-06-10 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
AU2007298549A1 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-IV
EP1958947A1 (en) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type 4
US20110130403A1 (en) * 2007-03-14 2011-06-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
AP2453A (en) 2007-03-14 2012-08-31 Ranbaxy Lab Ltd Pyrazolo(3,4-B) pyridine derivatives as phosphodiesterase inhibitors
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
US20110135737A1 (en) 2009-05-29 2011-06-09 Pearl Therapeutics, Inc. Compositions for respiratory delivery of active agents and associated methods and systems
PT105058B (pt) 2010-04-21 2013-04-17 Hovione Farmaciencia S A Processo para processamento de partículas de ingredientes activos farmacêuticos
AU2014228414B2 (en) 2013-03-15 2018-09-13 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
CN107260671B (zh) * 2016-04-08 2021-03-26 天津金耀集团有限公司 一种糠酸莫米松混悬鼻喷剂组合物
CN107266518B (zh) * 2016-04-08 2021-03-30 天津金耀集团有限公司 一种糠酸莫米松晶型及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE8790T1 (de) * 1981-02-02 1984-08-15 Schering Corporation Aromatische heterocyclische steroidester, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
US4783444A (en) 1984-09-17 1988-11-08 Schering Corporation Antiglaucoma compositions and methods
US4808610A (en) * 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
US4775529A (en) * 1987-05-21 1988-10-04 Schering Corporation Steroid lotion
KR960013445B1 (ko) * 1990-09-10 1996-10-05 쉐링 코포레이션 모메타손 푸로에이트 모노하이드레이트 및 이의 제조방법

Also Published As

Publication number Publication date
PL165803B1 (pl) 1995-02-28
DE69104991T2 (de) 1995-04-20
HRP920383B1 (en) 2000-04-30
HRP920383A2 (en) 1998-06-30
IE67056B1 (en) 1996-02-21
FI931031L (fi) 1993-03-09
CZ38393A3 (en) 1994-01-19
HU213401B (en) 1997-06-30
MX9100990A (es) 1992-05-04
OA09772A (en) 1993-11-30
CA2091360A1 (en) 1992-03-11
LU90366I2 (fr) 1999-05-05
HU9300685D0 (en) 1993-06-28
ATE113604T1 (de) 1994-11-15
NL980012I1 (nl) 1998-05-06
ES2065701T3 (es) 1995-02-16
PT98905B (pt) 1998-08-31
YU149791A (sh) 1994-01-20
EE02962B1 (et) 1997-02-17
CZ281318B6 (cs) 1996-08-14
MX9203396A (es) 1992-07-31
EP0548114B1 (en) 1994-11-02
DE19875032I2 (de) 2007-04-19
JPH05506667A (ja) 1993-09-30
NZ239711A (en) 1992-09-25
AU663471B2 (en) 1995-10-12
NO930693L (no) 1993-02-26
FI111078B (fi) 2003-05-30
US6180781B1 (en) 2001-01-30
HUT64361A (en) 1993-12-28
HK185996A (en) 1996-10-11
KR960013445B1 (ko) 1996-10-05
CN1059911A (zh) 1992-04-01
TW272195B (cs) 1996-03-11
CN1030920C (zh) 1996-02-07
JPH0725789B2 (ja) 1995-03-22
EP0548114A1 (en) 1993-06-30
SI9111497A (sl) 1998-04-30
CA2091360C (en) 1997-04-08
PT98905A (pt) 1992-09-30
IL99437A0 (en) 1992-08-18
TW229208B (cs) 1994-09-01
ZA917148B (en) 1992-08-26
DE69104991D1 (de) 1994-12-08
NL980012I2 (nl) 2004-11-01
FI931031A0 (fi) 1993-03-09
NO930693D0 (no) 1993-02-26
NO300548B1 (no) 1997-06-16
YU48666B (sh) 1999-06-15
IE913155A1 (en) 1992-03-11
AU8497491A (en) 1992-03-30
PH30443A (en) 1997-05-09
WO1992004365A1 (en) 1992-03-19
DK0548114T5 (da) 1995-01-30
MY106644A (en) 1995-07-31
IL99437A (en) 1995-05-29

Similar Documents

Publication Publication Date Title
BG60755B2 (bg) Мометазонфуроат монохидрат, метод за получаването му и фармацевтичен състав
US6127353A (en) Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
EP3459933B1 (en) Solid forms of a pharmaceutically active compound
US9981985B2 (en) Pharmaceutical formulations containing 3-(4-cinnamyl-l-piperazinyl) amino derivatives of 3-formylrifamycin SV and 3-formylrifamycin S and a process of their preparation
TW201906839A (zh) Bcl-2抑制劑之新結晶型、其製備方法及含其之醫藥組合物
EP0537555B1 (en) Crystalline etoposide 4'-phosphate diethanolate
KR20100125124A (ko) 피타바스타틴 헤미칼슘염의 신규한 결정형 및 그의 제조방법
TW202313617A (zh) ＰＩ３Ｋδ抑制劑的鹽、其晶型、製備方法及用途
CN116239527A (zh) 一种米力农-柠檬酸一水共晶体
EP2880040A1 (en) Bortezomib esters and formulations thereof